The PulseCalendarExplorerLongevity Clinics MapLongevity Investors MapWearables & Nearables MapAcademyCoursesMy LearningAbout

Masters of Longevity - The Pulse

Feature21 Jul 2026

Wellness promised us an easier life, yet gave Us 14 Things to Do Before Breakfast

Recovery should make us feel better — not give us more data, decisions and routines to manage. This opinion asks when self-care became another job, and what health technology should do differently.

A visibly worried person studies a phone whose screen faces away from the viewer, surrounded by wellness devices.

Editorial Picks

More from MoL
A physician discussing evidence-based preventive care with an older patient in a consultation room

Can Doctors Be Trained for the Longevity Era?

Editorial24 Jul 2026

ApoB

ApoB: The cholesterol signal LDL can miss

Editorial07 Jul 2026

Unlabeled biologic vials in front of body-composition scan imagery

The Next Obesity-Drug Race Is About What Weight You Lose

Editorial25 Jun 2026

health tracking stress

When Health Tracking Becomes Self-Surveillance

Lifestyle Brief24 Jun 2026

midjourney female_lower_abdomen

Midjourney’s Strange Leap Into Preventive Health

News22 Jun 2026

wearables and nearables map

Wearables, Nearables, And The New Body-Data Stack

MoL Research15 Jun 2026

Trending News

Based on last 48h engagement

  1. 01Can Doctors Be Trained for the Longevity Era? (Masters of Longevity)Can Doctors Be Trained for the Longevity Era?Masters of Longevity • 24 Jul 2026
  2. 02ECT Reprograms Adult Neurons into a Youthful State (Neuroscience News)ECT Reprograms Adult Neurons into a Youthful StateNeuroscience News • 17 Jul 2026
  3. 03Recall-By-Genotype for Precision Psychiatry (Neuroscience News)Recall-By-Genotype for Precision PsychiatryNeuroscience News • 25 Jul 2026
  4. 04Reversal of protein chemical aging by enzymatic deglycation (Nature - Biotechnology)Reversal of protein chemical aging by enzymatic deglycationNature - Biotechnology • 14 Jul 2026
  5. 05Fight Aging! Newsletter, July 27th 2026 (Fight Aging!)Fight Aging! Newsletter, July 27th 2026Fight Aging! • 26 Jul 2026

Upcoming Events

View calendar
  1. Longevity by Design (Santa Fe, United States)2. AUG 2026 - 6. AUG 2026Longevity by DesignRetreat - Santa Fe, USA
  2. LONGEVITY8 at Canyon Ranch Tucson (Tucson, United States)9. AUG 2026 - 13. AUG 2026LONGEVITY8 at Canyon Ranch TucsonRetreat - Tucson, USA
  3. Longevity Summit India 2026 (Mumbai, India)15. AUG 2026 - 16. AUG 2026Longevity Summit India 2026Summit - Mumbai, India
  4. 1st Annual Buck Institute Reproductive Aging Summit (Novato, United States)21. AUG 2026 · 08:30–18:001st Annual Buck Institute Reproductive Aging SummitSummit - Novato, USA
  5. Longevity Wellness Expo 2026 (Toronto, Canada)2. OCT 2026 - 4. OCT 2026Longevity Wellness Expo 2026Expo - Toronto, Canada★

Latest in Longevity

40+ high-signal longevity feeds, continuously monitored for you.

|←←→
Neuroscience News24 Jul 2026
Future Obesity Drugs to Target Specific Brain Circuits (Neuroscience News)

Future Obesity Drugs to Target Specific Brain Circuits

Reports how new mouse studies map opposing GIPR drug effects to distinct brain regions and outline circuit-based combination strategies.

Key takeaways
  • Neuroscience News More than a billion people worldwide are living with obesity.
  • New generation of weight loss drugs has emerged that target particular receptors in the brain.
  • One group of mice lacked GIPR in the brainstem – the area at the base of the brain.
Longevity Technology24 Jul 2026
AISerina Therapeutics completes cohort 1 dosing in Parkinson’s trial (Longevity Technology)

Serina Therapeutics completes cohort 1 dosing in Parkinson’s trial

Serina Therapeutics’ Parkinson’s trial update — a concise news article previewing cohort 1 dosing completion and an upcoming blinded safety review.

Key takeaways
  • Serina completed enrollment and dosing of all eight patients in Cohort 1 of its registrational trial.
  • Independent Safety Monitoring Committee will perform a blinded review of Cohort 1 safety and tolerability.
  • SER-252 is an investigational apomorphine therapy using a POZ poly(2-oxazoline) platform to enable controlled release.
PR Newswire24 Jul 2026
Roche receives FDA clearance for the cobas® BV/CV assay, enabling fast and highly accurate vaginitis diagnosis (PR Newswire)

Roche receives FDA clearance for the cobas® BV/CV assay, enabling fast and highly accurate vaginitis diagnosis

A news article about a newly cleared lab molecular test for diagnosing common causes of vaginitis, and what reading it offers clinicians and labs.

Key takeaways
  • It enables accurate and timely results that can lead to improved patient outcomes and enhanced healthcare efficiencies.
  • 3 Clinicians have traditionally relied on less precise methods such as microscopy.
  • Vaginitis is one of the most common reasons women visit a healthcare provider.
Fitt Insider - Press Releases24 Jul 2026
AINew Study Finds PeptiStrong® Outperforms Leucine and HMB in Aging Muscle, and Works Even Better in Combination (Fitt Insider - Press Releases)

New Study Finds PeptiStrong® Outperforms Leucine and HMB in Aging Muscle, and Works Even Better in Combination

PeptiStrong’s effects on aging muscle are examined in a lab study; readers will find a clear comparison with common supplements and combination implications.

Key takeaways
  • Novel aging muscle cell model was used to evaluate muscle anabolic signaling responses.
  • PeptiStrong activated muscle-building signaling via a leucine-independent pathway in the model.
  • Combining PeptiStrong with leucine or HMB produced greater signaling effects than single agents.